Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
Differentiating between axonal damage and demyelination in healthy aging by combining diffusion-tensor imaging and diffusion-weighted spectroscopy in the human corpus callosum at 7 T.
The association of pathological laughing and crying and cognitive impairment in multiple sclerosis.
[PHYSICAL EXERCISE FOR PEOPLE WITH MULTIPLE SCLEROSIS: EFFECTS, RECOMMENDATIONS AND BARRIERS].
Terminal complement activation is increased and associated with disease severity in CIDP.
Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine.
Cutting Edge: ACVRL1 Signaling Augments CD8α+ Dendritic Cell Development.
Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.
Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement.
Pediatric multiple sclerosis: Escalation and emerging treatments.
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression.
Characterizing retinal structure injury in African-Americans with multiple sclerosis.
Living with uncertainty and hope: A qualitative study exploring parents' experiences of living with childhood multiple sclerosis.
Epigenetic Aspects of Systemic Lupus Erythematosus.
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses.
14-3-3 proteins regulate K2P 5.1 surface expression on T lymphocytes.
Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity.
The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey.
Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.
Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial.
SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
Age-related changes in the function and structure of the peripheral sensory pathway in mice.
Long-term outcome of changes in cognitive function of young rats after various/different doses of whole brain irradiation.
Mapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells.
Pages
« first
‹ previous
…
717
718
719
720
721
722
723
724
725
…
next ›
last »